Lv3
336 积分 2024-07-31 加入
177Lu-Dotatate plus long-acting octreotide versus high‑dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial
2天前
已完结
Immune mediators as therapeutic targets in GvHD; cytokines, growth factors, chemokines, and co-stimulation /co-inhibition
16天前
已关闭
Barriers to Health Care Access for People with Hidradenitis Suppurativa
19天前
已关闭
Hidradenitis suppurativa
19天前
已关闭
Induction with ATG in DCD kidney transplantation; efficacy and relation of dose and cell markers on delayed graft function and renal function
25天前
已关闭
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for colorectal neuroendocrine tumours
27天前
已完结
肛门直肠周围脓肿临床诊治专家共识（2025版）
1个月前
已关闭
皖公网安备34019202002308
